University Hospital Zurich, Division of Infectious Diseases and Hospital Epidemiology and University of Zurich, Zurich, Switzerland.
Department of Clinical Nursing Science & Department of Perioperative Medicine, Kantonsspital Aarau, Aaurau, Switzerland.
J Hosp Infect. 2021 Apr;110:26-32. doi: 10.1016/j.jhin.2021.01.007. Epub 2021 Jan 20.
Daily chlorhexidine bathing has been associated with a reduction in central line-associated bloodstream infections (CLABSI). In the setting of an already established CLABSI surveillance system and an implemented CLABSI prevention bundle, we analysed the effect of daily chlorhexidine bathing in ICU patients on CLABSI incidence and its causative pathogens.
This was a before-and-after study in intensive care units (ICUs) at a tertiary-care centre in Switzerland. Prospective surveillance of CLABSIs and their aetiologies was established. The intervention consisted of daily chlorhexidine bathing of ICU patients with a central venous catheter. A baseline period of 19 months was followed by an intervention period of 9 months.
A total of 5008 patients were included. In the baseline period a mean CLABSI rate of 2.45/1000 catheter days (95% confidence interval (CI) 1.93-3.07) was observed, followed by 1.00/1000 catheter days (95% CI 0.55-1.67; P<0.001) in the intervention period. Introduction of chlorhexidine bathing was independently associated with a reduced risk of CLABSI (adjusted odds ratio 0.47, 95% CI 0.26-0.84, P=0.011). We did not observe a significant change in aetiology except for an increase of Serratia marcescens in the intervention period.
Introduction of daily chlorhexidine bathing resulted in a decline in CLABSI incidence on ICUs. Starting from a baseline CLABSI rate that can be considered standard in a high-income setting and several measures for CLABSI prevention implemented, chlorhexidine bathing proved helpful for a further reduction.
每日用洗必泰进行沐浴与中心静脉相关血流感染(CLABSI)的减少有关。在已经建立的 CLABSI 监测系统和实施的 CLABSI 预防措施的基础上,我们分析了 ICU 患者每日使用洗必泰沐浴对 CLABSI 发生率及其病原体的影响。
这是瑞士一家三级医疗中心的 ICU 进行的前后对照研究。建立了 CLABSIs 和病原体的前瞻性监测。干预措施包括对有中心静脉导管的 ICU 患者进行每日洗必泰沐浴。在 19 个月的基线期后,进行了 9 个月的干预期。
共纳入 5008 例患者。在基线期,平均 CLABSI 发生率为 2.45/1000 导管日(95%可信区间 1.93-3.07),干预期为 1.00/1000 导管日(95%可信区间 0.55-1.67;P<0.001)。引入洗必泰沐浴与 CLABSI 风险降低独立相关(校正比值比 0.47,95%可信区间 0.26-0.84,P=0.011)。除了干预期粘质沙雷氏菌的增加外,我们没有观察到病因学的显著变化。
在 ICU 中引入每日洗必泰沐浴可降低 CLABSI 的发生率。在实施了几种 CLABSI 预防措施并达到高收入国家设定的 CLABSI 发生率标准的基础上,每日洗必泰沐浴有助于进一步降低 CLABSI 的发生率。